HomeCompareUSCRX vs CL

USCRX vs CL: Dividend Comparison 2026

USCRX yields 10.64% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CL wins by $409.00 in total portfolio value· pulled ahead in Year 10
10 years
USCRX
USCRX
● Live price
10.64%
Share price
$26.90
Annual div
$2.86
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.4K
Annual income
$2,072.24
Full USCRX calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — USCRX vs CL

📍 CL pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUSCRXCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, USCRX + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
USCRX pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

USCRX
Annual income on $10K today (after 15% tax)
$904.11/yr
After 10yr DRIP, annual income (after tax)
$1,761.40/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, CL beats the other by $2,830.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of USCRX + CL for your $10,000?

USCRX: 50%CL: 50%
100% CL50/50100% USCRX
Portfolio after 10yr
$40.6K
Annual income
$3,737.10/yr
Blended yield
9.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

USCRX
No analyst data
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

USCRX buys
0
CL buys
0
No recent congressional trades found for USCRX or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUSCRXCL
Forward yield10.64%2.43%
Annual dividend / share$2.86$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$40.4K$40.8K
Annual income after 10y$2,072.24$5,401.96
Total dividends collected$15.6K$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: USCRX vs CL ($10,000, DRIP)

YearUSCRX PortfolioUSCRX Income/yrCL PortfolioCL Income/yrGap
1$11,764$1,063.66$11,012$312.01+$752.00USCRX
2$13,757$1,169.39$12,196$412.95+$1.6KUSCRX
3$15,997$1,278.03$13,599$549.66+$2.4KUSCRX
4$18,506$1,389.00$15,288$736.64+$3.2KUSCRX
5$21,303$1,501.71$17,353$995.28+$4.0KUSCRX
6$24,410$1,615.60$19,926$1,357.80+$4.5KUSCRX
7$27,849$1,730.11$23,194$1,873.82+$4.7KUSCRX
8$31,643$1,844.71$27,439$2,621.52+$4.2KUSCRX
9$35,817$1,958.91$33,088$3,727.38+$2.7KUSCRX
10← crossover$40,397$2,072.24$40,806$5,401.96$409.00CL

USCRX vs CL: Complete Analysis 2026

USCRXStock

The fund invests in equity securities, bonds, money market instruments, and other instruments including derivatives. It has a target asset class allocation of approximately 60% equity securities and 40% fixed-income securities. The actual asset class allocation can deviate from time to time from these targets as market conditions warrant. The implementation of the asset allocation may involve the extensive use of equity and fixed-income ETFs. The fund also may invest in investment-grade and below-investment-grade fixed-income securities.

Full USCRX Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this USCRX vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

USCRX vs SCHDUSCRX vs JEPIUSCRX vs OUSCRX vs KOUSCRX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.